Transarterial therapies for the treatment of intrahepatic cholangiocarcinoma.

Abstract

Cholangiocarcinoma, whether arising from the intrahepatic or extrahepatic biliary system, is a rare but devastating malignancy. Prognosis is poor, with 5-year overall survival <5% including patients undergoing surgery. Resection is the only curative treatment; however, only ∼30% of patients present at a resectable stage, and intrahepatic recurrence is common even after complete resection. This article discusses the current role of transarterial therapies in the treatment of intrahepatic cholangiocarcinoma.

DOI: 10.1055/s-0033-1333650
05010020132014201520162017
Citations per Year

86 Citations

Semantic Scholar estimates that this publication has 86 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Zechlinski2013TransarterialTF, title={Transarterial therapies for the treatment of intrahepatic cholangiocarcinoma.}, author={Joseph John Zechlinski and William S. Rilling}, journal={Seminars in interventional radiology}, year={2013}, volume={30 1}, pages={21-7} }